Order Article Reprints

Zhuo X, Margrethe Brekstad Kjellin M, Schaal Z, Zhang T, Löbmann K, Leng D. A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. Pharmaceutics. 2023; 15(1):126. https://doi.org/10.3390/pharmaceutics15010126

Zhuo, Xuezhi, Maud Margrethe Brekstad Kjellin, Zarah Schaal, Tengyu Zhang, Korbinian Löbmann, and Donglei Leng. 2023. "A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin" Pharmaceutics 15, no. 1: 126. https://doi.org/10.3390/pharmaceutics15010126

Zhuo, X., Margrethe Brekstad Kjellin, M., Schaal, Z., Zhang, T., Löbmann, K., & Leng, D. (2023). A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. Pharmaceutics, 15(1), 126. https://doi.org/10.3390/pharmaceutics15010126